Pelthos Therapeutics PTHS
NYSE PTHS
$26.40 -0.26 (-0.99%)
As of: Aug 21, 2026 · 10:36 AM EDT

Pelthos Therapeutics (PTHS) Construction in Progress (2025)

Pelthos Therapeutics (PTHS) posted quarterly Construction in Progress of $1.7 million for Q3 2025.

Pelthos Therapeutics (PTHS) Construction in Progress (2025) Analysis & Trends

Pelthos Therapeutics' Construction in Progress history runs 1 years deep, the most recent figure standing at $1.7 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Vertex Pharmaceuticals 140.29 Bn 132.43 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.58 Bn 78.58 Bn 3.93 Bn -
3 Argenx Se 65.26 Bn 60.08 Bn 1.37 Bn -
4 Moderna 61.87 Bn 56.73 Bn 52.00 Mn -
5 BeOne Medicines 42.18 Bn 37.08 Bn 1.53 Bn 152.67 Mn
6 Alnylam Pharmaceuticals 31.51 Bn 28.20 Bn 992.69 Mn -
7 BioNTech SE 28.90 Bn 10.51 Bn 668.28 Mn -
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -
9 Royalty Pharma 27.24 Bn 26.41 Bn - -
10 Pelthos Therapeutics 93.44 Mn 68.88 Mn 21.23 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 1.74 Mn